Related Experiment Video
Updated: Jan 29, 2026

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
MicroRNAs in Major Depressive Disorder
Gabriel R Fries1, Wei Zhang1, Deborah Benevenuto1
1Translational Psychiatry Program, Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA.
Abstract:
Major depressive disorder (MDD) is a severe and chronic psychiatric disorder with a high prevalence in the population. Although our understanding of its pathophysiological mechanisms has significantly increased over the years, available treatments still present several limitations and are not effective to all MDD patients. Epigenetic mechanisms have recently been suggested to play key roles in MDD pathogenesis and treatment, including the effects of small noncoding RNAs known as microRNAs (miRNAs). miRNAs can modulate gene expression posttranscriptionally by interfering with the stability and translation of messenger RNA molecules and are also known to cross-talk with other epigenetic mechanisms. In this review, we will summarize and discuss recent findings of alterations in miRNAs in tissues of patients with MDD and evidence of treatment-induced effects in these molecules.
Insights
MicroRNAs (miRNAs) show altered expression in major depressive disorder (MDD) and may be influenced by treatment. This review explores their role in MDD pathogenesis and therapeutic potential.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Major depressive disorder (MDD) is a prevalent, chronic psychiatric condition with limited treatment efficacy.
- Current understanding of MDD pathophysiology is incomplete, necessitating novel therapeutic targets.
Purpose of the Study:
- To review current findings on microRNA (miRNA) alterations in MDD patients.
- To discuss the role of miRNAs in MDD pathogenesis and treatment response.
Main Methods:
- Literature review of studies investigating miRNA expression in MDD.
- Analysis of research on miRNA's epigenetic regulatory functions.
- Examination of treatment-induced changes in miRNA profiles.
Main Results:
- Evidence suggests significant alterations in miRNA expression in tissues from MDD patients.
- miRNAs are implicated in post-transcriptional gene regulation relevant to MDD.
- Emerging data indicate miRNAs are modulated by antidepressant treatments.
Conclusions:
- miRNAs represent a promising area for understanding MDD.
- miRNA-based biomarkers and therapeutics warrant further investigation for MDD.
Related Concept Videos
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Depressive Disorders: MDD and Dysthymia
MicroRNAs
MicroRNAs
Long-term Depression
Freezing Point Depression and Boiling Point Elevation
The boiling point of a liquid is the temperature at which its vapor pressure is equal to ambient atmospheric pressure. Since the vapor pressure of a solution is lowered due to the presence of nonvolatile solutes, it stands to reason that the solution’s boiling point will subsequently be increased. Vapor pressure increases with temperature, and so a solution will require a higher temperature than will pure solvent to achieve any given vapor pressure, including one...

